loadpatents
name:-0.082719087600708
name:-0.032451868057251
name:-0.018821001052856
HAN; Yong Mahn Patent Filings

HAN; Yong Mahn

Patent Applications and Registrations

Patent applications and USPTO patent grants for HAN; Yong Mahn.The latest application filed is for "pharmaceutical composition for preventing or treating fabry disease, containing tsp1 protein inhibitor as active ingredient".

Company Profile
3.8.14
  • HAN; Yong Mahn - Daejeon KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical Composition For Preventing Or Treating Fabry Disease, Containing Tsp1 Protein Inhibitor As Active Ingredient
App 20220034908 - HAN; Yong Mahn ;   et al.
2022-02-03
Composition For Preventing Or Treating Cardiofaciocutaneous Syndrome
App 20210284705 - Han; Yong Mahn ;   et al.
2021-09-16
Composition for preventing or treating cardiofaciocutaneous syndrome
Grant 11,059,875 - Han , et al. July 13, 2
2021-07-13
Composition For Preventing Or Treating Cardiofaciocutaneous Syndrome
App 20190241635 - Han; Yong Mahn ;   et al.
2019-08-08
Induced pluripotent stem cell model for Fabry disease and use thereof
Grant 10,287,554 - Han , et al.
2019-05-14
Induced pluripotent stem cell model for cardiofaciocutaneous syndrome and uses thereof
Grant 10,174,288 - Han , et al. J
2019-01-08
Method For Improvement Of Drug Metabolism Of Human Stem Cell-derived Hepatocytes
App 20180163179 - JEONG; Won-il ;   et al.
2018-06-14
Method for preparing endocrine aggregate of insulin-producing beta cells from human pluripotent stem cells
Grant 9,988,605 - Han , et al. June 5, 2
2018-06-05
Composition for preventing and treating acetaminophen inducing hepatotoxicity containing TNP(N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine) as an effective ingredient
Grant 9,636,343 - Kim , et al. May 2, 2
2017-05-02
Immune Hepatotoxicity Screening Method Using Hepatocytes Derived From Human Stem Cells
App 20170052172 - LEE; Seung-Hyo ;   et al.
2017-02-23
Induced Pluripotent Stem Cell Model Of Noonan Syndrome And Use Thereof
App 20170016886 - HAN; Yong-Mahn ;   et al.
2017-01-19
Composition for Preventing and Treating Acetaminophen Inducing Hepatotoxicity Containing TNP(N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine) as an Effective Ingredient
App 20160354378 - KIM; Seyun ;   et al.
2016-12-08
Induced Pluripotent Stem Cell Model for Cardiofaciocutaneous Syndrome and Uses Thereof
App 20160355788 - HAN; Yong-Mahn ;   et al.
2016-12-08
Method For Generating Cardiomyocytes
App 20160151451 - CHO; Sung Woo ;   et al.
2016-06-02
Induced Pluripotent Stem Cell Model For Fabry Disease And Use Thereof
App 20150361401 - Han; Yong-mahn ;   et al.
2015-12-17
Method For Preparing Endocrine Aggregate Of Insulin-producing Beta Cells From Human Pluripotent Stem Cells
App 20150159140 - HAN; Yong-mahn ;   et al.
2015-06-11
Method of inducing differentiation of embryonic stem cells into hemangioblast
Grant 8,507,275 - Han , et al. August 13, 2
2013-08-13
Cattle beta-casein gene targeting vector using homologous recombination
Grant 8,030,538 - Han , et al. October 4, 2
2011-10-04
Method Of Inducing Differentiation Of Embryonic Stem Cells Into Hemangioblast
App 20110027886 - Han; Yong-Mahn ;   et al.
2011-02-03
Cattle Beta-casein Gene Targeting Vector Using Homologous Recombination
App 20090013419 - Han; Yong-Mahn ;   et al.
2009-01-08
Transgenic goat producing milk containing human granulocyte-colony stimulating factor
App 20030051257 - Jin, Seung-Won ;   et al.
2003-03-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed